Evidence map›Paper›PMID 18657231›Full record

ArticleJournal of cellular and molecular medicine2009

Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells.

David M Smadja, Ivan Bièche, Sophie Susen, Laetitia Mauge, Ingrid Laurendeau, Clément d'Audigier, Françoise Grelac, Joseph Emmerich, Martine Aiach, Pascale Gaussem

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

David M SmadjaUniversité Paris Descartes, Faculté de Pharmacie, Paris, France.
Ivan BiècheUniversité Paris Descartes, Faculté de Pharmacie, Paris, France.
Sophie SusenInserm U765, Paris, France.
Laetitia MaugeInserm U765, Paris, France.
Ingrid LaurendeauUniversité Paris Descartes, Faculté de Pharmacie, Paris, France.
Clément d'AudigierInserm U765, Paris, France.
Françoise GrelacInserm U765, Paris, France.
Joseph EmmerichUniversité Paris Descartes, Faculté de Pharmacie, Paris, France.
Martine AiachUniversité Paris Descartes, Faculté de Pharmacie, Paris, France.
Pascale GaussemUniversité Paris Descartes, Faculté de Pharmacie, Paris, France.
Délégation Paris 5 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proinflammatory chemokine interleukin 8 exerts potent angiogenic effects on endothelial cells by interacting with its receptors CXCR1 and CXCR2. As thrombin is also a potent inflammatory factor, and as endothelial progenitor cells (EPC) express functional PAR-1 thrombin receptor, we examined whether PAR-1 stimulation interferes with the IL-8 pathway in EPC. EPC were obtained from adult blood (AB) and cord blood (CB). The effect of PAR-1 stimulation by the peptide SFLLRN on IL-8, CXCR1 and CXCR2 expression was examined by RTQ-PCR and at the protein level in AB and CB late EPC and in AB early EPC. Specific siRNA was used to knock down PAR-1 expression. The IL-8 gene was expressed strongly in AB early EPC and moderately in late EPC. In contrast, CXCR1 and CXCR2 gene expression was restricted to AB early EPC. The IL-8 level in AB early EPC conditioned medium was high in basal conditions and did not change after PAR-1 activation. By contrast, IL-8 secretion by late EPC was low in basal conditions and strongly up-regulated upon PAR-1 activation. PAR-1 activation induced a number of genes involved in activating protein-1 (AP-1) and nuclear factor (NF)-kappaB pathways. Conditioned medium of PAR-1-activated late EPC enhanced the migratory potential of early EPC, and this effect was abrogated by blocking IL-8. Target-specific siRNA-induced PAR-1 knockdown, and fully inhibited PAR-1-induced IL-8 synthesis. In conclusion, PAR-1 activation induces IL-8 synthesis by late EPC. This could potentially enhance cooperation between late and early EPC during neovascularization, through a paracrine effect.

Indexed as

AdultBase SequenceBlotting, WesternDNA PrimersEndothelium, VascularEnzyme-Linked Immunosorbent AssayFlow CytometryHumansImmunohistochemistryInterleukin-8Receptor, PAR-1Reverse Transcriptase Polymerase Chain ReactionDNA PrimersInterleukin-8Receptor, PAR-1

Identifiers

PMID18657231
PMCPMC6512392
OpenAlexW2014969023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.